PATIENTS CURE THERAPEUTICS LIMITED

Company Registration Number:
14069594 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

PATIENTS CURE THERAPEUTICS LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

PATIENTS CURE THERAPEUTICS LIMITED

Company Information

for the Period Ended 30 April 2024




Director: Elizabeth Sampong Mireku
Registered office: 1
Hall View
Mattersey
Doncaster
England
DN10 5HY
Company Registration Number: 14069594 (England and Wales)

PATIENTS CURE THERAPEUTICS LIMITED

Directors' Report Period Ended 30 April 2024

The directors present their report with the financial statements of the company for the period ended 30 April 2024

Directors

The director(s) shown below were appointed to the company during the period
Elizabeth Sampong Mireku
01 May 2023

This report was approved by the board of directors on 26 August 2024
And Signed On Behalf Of The Board By:

Name: Elizabeth Sampong Mireku
Status: Director

PATIENTS CURE THERAPEUTICS LIMITED

Profit and Loss Account

for the Period Ended 30 April 2024


Notes

2024
£

2023
£
Turnover 0 0
Cost of sales ( 0 ) ( 0 )
Gross Profit or (Loss) 0 0
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 30,000 ) ( 29,100 )
Other operating income 0 0
Operating Profit or (Loss) ( 30,000 ) ( 29,100 )
Profit or (Loss) Before Tax ( 30,000 ) ( 29,100 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 30,000 ) ( 29,100 )

The notes form part of these financial statements

PATIENTS CURE THERAPEUTICS LIMITED

Balance sheet

As at 30 April 2024


Notes

2024
£

2023
£
Fixed assets
Intangible assets: 4 0 0
Tangible assets: 5 0 0
Total fixed assets: 0 0
Current assets
Stocks: 1 1
Debtors: 6 0 0
Cash at bank and in hand: 0 0
Total current assets: 1 1
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 7 ( 0 ) ( 0 )
Net current assets (liabilities): 1 1
Total assets less current liabilities: 1 1
Creditors: amounts falling due after more than one year: 8 ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 1 1

The notes form part of these financial statements

PATIENTS CURE THERAPEUTICS LIMITED

Balance sheet continued

As at 30 April 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1 1
Revaluation reserve: 9 0 0
Profit and loss account: 0 0
Shareholders funds: 1 1

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 26 August 2024
And Signed On Behalf Of The Board By:

Name: Elizabeth Sampong Mireku
Status: Director

The notes form part of these financial statements

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 3. Off balance sheet disclosure

    No

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

4. Intangible assets

Other Total
Cost £ £
At 01 May 2023 - -
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 30 April 2024 - -
Amortisation
Amortisation at 01 May 2023 - -
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 30 April 2024 - -
Net book value
Net book value at 30 April 2024 - -
Net book value at 30 April 2023 - -

intangible asset 0

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

5. Tangible assets

Office equipment Total
Cost £ £
At 01 May 2023 - -
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 30 April 2024 - -
Depreciation
At 01 May 2023 - -
Charge for year - -
On disposals - -
Other adjustments - -
At 30 April 2024 - -
Net book value
At 30 April 2024 - -
At 30 April 2023 - -

Net book value at 1

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

6. Debtors


2024
£

2023
£
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 0
Total 0 0
Debtors due after more than one year: 0 0

0

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

7.Creditors: amounts falling due within one year note


2024
£

2023
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 0 0
Other creditors 0 0
Total 0 0

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

8.Creditors: amounts falling due after more than one year


2024
£

2023
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 0 0
Total 0 0

PATIENTS CURE THERAPEUTICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

9. Revaluation reserve


2024
£
Balance at 01 May 2023 0
Surplus or deficit after revaluation 0
Balance at 30 April 2024 0